|
mRNA_ID
|
Gene Name
|
drug_ID
|
drug_Name
|
Disease
|
RNA_exp_pattern
|
Evidence
|
Details
|
|
ENST00000612628
|
TJP1
|
DB05134
|
Tanespimycin
|
posterior capsule opacification
|
down-regulated
|
validated
|
more...
|
|
ENST00000221930
|
TGFB1
|
DB05134
|
Tanespimycin
|
posterior capsule opacification
|
down-regulated
|
validated
|
more...
|
|
ENST00000216281
|
HSP90AA1
|
DB05134
|
Tanespimycin
|
posterior capsule opacification
|
down-regulated
|
validated
|
more...
|
|
ENST00000371646
|
HSP90AB1
|
DB05134
|
Tanespimycin
|
posterior capsule opacification
|
down-regulated
|
validated
|
more...
|
|
ENST00000324642
|
TERT
|
DB05134 (DB06398)
|
Troglitazone
|
breast cancer
|
down-regulated
|
validated
|
more...
|
|
ENST00000267868
|
RAD51
|
DB05134 (DB06398)
|
Tanespimycin(17-AAG)
|
lung cancer
|
down-regulated
|
validated
|
more...
|
|
ENST00000216281
|
HSP90
|
DB05134 (DB06398)
|
Tanespimycin(17AAG)
|
pancreatic cancer
|
down-regulated
|
validated
|
more...
|
|
ENST00000242057
|
AHR
|
DB05134 (DB06398)
|
Tanespimycin(17AAG)
|
lung cancer
|
down-regulated
|
validated
|
more...
|
|
ENST00000216281
|
HSP90
|
DB05134 (DB06398)
|
Tanespimycin
|
breast cancer
|
down-regulated
|
validated
|
more...
|